Compare MF & CURX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MF | CURX |
|---|---|---|
| Founded | N/A | 2018 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.5M | 7.9M |
| IPO Year | 2021 | 2024 |
| Metric | MF | CURX |
|---|---|---|
| Price | $17.00 | $5.08 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 118.8K | 22.9K |
| Earning Date | N/A | 09-09-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.07 | $0.18 |
| 52 Week High | $22.56 | $6.80 |
| Indicator | MF | CURX |
|---|---|---|
| Relative Strength Index (RSI) | 62.98 | 68.58 |
| Support Level | $12.49 | $3.91 |
| Resistance Level | $19.63 | $6.00 |
| Average True Range (ATR) | 1.72 | 0.41 |
| MACD | 0.07 | -0.08 |
| Stochastic Oscillator | 100.00 | 87.33 |
Curanex Pharmaceuticals Inc is engaged in discovering, developing, and commercializing botanical drugs for treating unmet medical needs in patients with inflammatory disease. Its compound, Phyto-N, is in preclinical research for six indications: ulcerative colitis, atopic dermatitis, COVID-19, type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) and gout. Phyto-N, is a proprietary botanical extract with chemical components and pharmacological activities that harnesses potential anti-inflammatory properties of a medicinal plant.